Northern Trust
NKGN

Northern Trust’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Northern Trust’s Portfolio NKGN Stock Details NKGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-29,082
Closed -$19.1K – 4525
2024
Q4 		$19.1K Hold
29,082
– – ﹤0.01% 4379
2024
Q3 		$11K Hold
29,082
– – ﹤0.01% 4374
2024
Q2 		$36.9K Buy
29,082
+13,360
+85% +$18.7K ﹤0.01% 4255
2024
Q1 		$29.7K Hold
15,722
– – ﹤0.01% 4298
2023
Q4 		$43.2K Buy
+15,722
New +$50.7K ﹤0.01% 4260

Other funds holding NKGN

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Northern Trust's NKGN Position: Q1 2025 in Review

Northern Trust sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q1 2025, closing a stake of 29,082 shares — an estimated $19.1K sold.

Northern Trust first reported a position in NKGN in Q4 2023 and held it in 5 quarters. The position peaked at $43.2K in Q4 2023. 3 funds tracked by Wall St. Rank hold NKGN as of Q1 2025.

  • Northern Trust reported no remaining NKGen Biotech, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Northern Trust sold 29,082 NKGen Biotech, Inc. Common Stock shares in Q1 2025, an estimated $19.1K.
  • Northern Trust first reported a position in NKGen Biotech, Inc. Common Stock in Q4 2023 and held it in 5 quarters.
  • Northern Trust's NKGen Biotech, Inc. Common Stock position peaked at $43.2K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q1 2025.

Based on Northern Trust's 13F filing for Q1 2025, filed 13 May 2025.